يعرض 5,041 - 5,060 نتائج من 9,147 نتيجة بحث عن 'significantly ((((((step decrease) OR (we decrease))) OR (nn decrease))) OR (observed decrease))', وقت الاستعلام: 0.62s تنقيح النتائج
  1. 5041

    Supplementary Material for: ACOT4 and ACOT6 activate Akt-mTOR pathway and inhibit calcium oxalate-induced renal tubular cell injury حسب figshare admin karger (2628495)

    منشور في 2025
    "…We also observed that knockdown of ACOT4 and ACOT6 induced the apoptosis of HK-2 cells after CaOx treatment. …"
  2. 5042

    Data Sheet 1_Real world evidence of dupilumab effectiveness in a Colombian cohort of patients diagnosed with severe asthma.docx حسب Abraham Alí-Munive (21347201)

    منشور في 2025
    "…The proportion of patients with uncontrolled asthma (ACT ≤15) decreased from 68% at baseline to 19% and 20% at year-one and second year of treatment, respectively (p = 0.003). …"
  3. 5043

    Image 4_Low miR-936-mediated upregulation of Pim-3 drives sorafenib resistance in liver cancer through ferroptosis inhibition by activating the ANKRD18A/Src/NRF2 pathway.jpeg حسب Xiao Li (107004)

    منشور في 2024
    "…MiR-936 overexpression and GV102-Pim-3-shRNA significantly attenuated the activity of the ANKRD18A/Src/NRF2 pathway to decrease the expression of Ankyrin repeat domain-containing protein 18A (ANKRD18A), Src, and Nuclear factor (erythroid-derived 2)-like 2 (NRF2), especially decreasing NRF2 nuclear retention and transcriptional activity. …"
  4. 5044

    Image 2_Low miR-936-mediated upregulation of Pim-3 drives sorafenib resistance in liver cancer through ferroptosis inhibition by activating the ANKRD18A/Src/NRF2 pathway.jpeg حسب Xiao Li (107004)

    منشور في 2024
    "…MiR-936 overexpression and GV102-Pim-3-shRNA significantly attenuated the activity of the ANKRD18A/Src/NRF2 pathway to decrease the expression of Ankyrin repeat domain-containing protein 18A (ANKRD18A), Src, and Nuclear factor (erythroid-derived 2)-like 2 (NRF2), especially decreasing NRF2 nuclear retention and transcriptional activity. …"
  5. 5045

    Image 1_Low miR-936-mediated upregulation of Pim-3 drives sorafenib resistance in liver cancer through ferroptosis inhibition by activating the ANKRD18A/Src/NRF2 pathway.jpeg حسب Xiao Li (107004)

    منشور في 2024
    "…MiR-936 overexpression and GV102-Pim-3-shRNA significantly attenuated the activity of the ANKRD18A/Src/NRF2 pathway to decrease the expression of Ankyrin repeat domain-containing protein 18A (ANKRD18A), Src, and Nuclear factor (erythroid-derived 2)-like 2 (NRF2), especially decreasing NRF2 nuclear retention and transcriptional activity. …"
  6. 5046

    Image 5_Low miR-936-mediated upregulation of Pim-3 drives sorafenib resistance in liver cancer through ferroptosis inhibition by activating the ANKRD18A/Src/NRF2 pathway.jpeg حسب Xiao Li (107004)

    منشور في 2024
    "…MiR-936 overexpression and GV102-Pim-3-shRNA significantly attenuated the activity of the ANKRD18A/Src/NRF2 pathway to decrease the expression of Ankyrin repeat domain-containing protein 18A (ANKRD18A), Src, and Nuclear factor (erythroid-derived 2)-like 2 (NRF2), especially decreasing NRF2 nuclear retention and transcriptional activity. …"
  7. 5047

    Table 1_Low miR-936-mediated upregulation of Pim-3 drives sorafenib resistance in liver cancer through ferroptosis inhibition by activating the ANKRD18A/Src/NRF2 pathway.docx حسب Xiao Li (107004)

    منشور في 2024
    "…MiR-936 overexpression and GV102-Pim-3-shRNA significantly attenuated the activity of the ANKRD18A/Src/NRF2 pathway to decrease the expression of Ankyrin repeat domain-containing protein 18A (ANKRD18A), Src, and Nuclear factor (erythroid-derived 2)-like 2 (NRF2), especially decreasing NRF2 nuclear retention and transcriptional activity. …"
  8. 5048

    Image 3_Low miR-936-mediated upregulation of Pim-3 drives sorafenib resistance in liver cancer through ferroptosis inhibition by activating the ANKRD18A/Src/NRF2 pathway.jpeg حسب Xiao Li (107004)

    منشور في 2024
    "…MiR-936 overexpression and GV102-Pim-3-shRNA significantly attenuated the activity of the ANKRD18A/Src/NRF2 pathway to decrease the expression of Ankyrin repeat domain-containing protein 18A (ANKRD18A), Src, and Nuclear factor (erythroid-derived 2)-like 2 (NRF2), especially decreasing NRF2 nuclear retention and transcriptional activity. …"
  9. 5049

    Data Sheet 1_Unilateral biportal endoscopic transforaminal lumbar interbody fusion versus minimally invasive transforaminal lumbar interbody fusion for single-level lumbar spondylo... حسب Yu Zhang (12946)

    منشور في 2025
    "…No significant differences were observed between both groups regarding disc height, lumbar lordosis, fusion rates, or complication rates (p > 0.05).…"
  10. 5050

    Data Sheet 2_Unilateral biportal endoscopic transforaminal lumbar interbody fusion versus minimally invasive transforaminal lumbar interbody fusion for single-level lumbar spondylo... حسب Yu Zhang (12946)

    منشور في 2025
    "…No significant differences were observed between both groups regarding disc height, lumbar lordosis, fusion rates, or complication rates (p > 0.05).…"
  11. 5051

    Supplementary file 1_Association of antenatal dexamethasone administration timing with outcomes in preterm infants in a low- and middle-income country.docx حسب Vijay Kalrao (22696397)

    منشور في 2025
    "…No other secondary outcomes differed significantly.</p>Conclusion<p>Dexamethasone administration within 24 h before delivery did not reduce mortality but significantly decreased the risk of severe NEC. …"
  12. 5052

    Data Sheet 4_Unilateral biportal endoscopic transforaminal lumbar interbody fusion versus minimally invasive transforaminal lumbar interbody fusion for single-level lumbar spondylo... حسب Yu Zhang (12946)

    منشور في 2025
    "…No significant differences were observed between both groups regarding disc height, lumbar lordosis, fusion rates, or complication rates (p > 0.05).…"
  13. 5053

    Data Sheet 3_Unilateral biportal endoscopic transforaminal lumbar interbody fusion versus minimally invasive transforaminal lumbar interbody fusion for single-level lumbar spondylo... حسب Yu Zhang (12946)

    منشور في 2025
    "…No significant differences were observed between both groups regarding disc height, lumbar lordosis, fusion rates, or complication rates (p > 0.05).…"
  14. 5054

    Structure of the OHC model. حسب Yihan Liao (13807348)

    منشور في 2025
    "…<p>In this study, we employed Depthwise Separable Convolution to significantly reduce the model's parameters, decreasing complexity, thus expediting training and reducing the risk of overfitting. …"
  15. 5055

    Video 2_Case Report: Allogeneic adipose-derived mesenchymal stem cells for severe feline chronic kidney disease.mp4 حسب Yizhe Song (11859734)

    منشور في 2025
    "…Concurrently, laboratory results revealed a decrease in key renal biomarkers (SCr, BUN, and P) and an amelioration of the non-regenerative anemia. …"
  16. 5056

    Sample size in each occupational subgroup. حسب Maryam Rafiee (10368504)

    منشور في 2025
    "…The highest prevalence of WMSDs (89.5%) was observed in the lower back region among women aged 45–54 years. …"
  17. 5057

    Correlation between different study variables. حسب Maryam Rafiee (10368504)

    منشور في 2025
    "…The highest prevalence of WMSDs (89.5%) was observed in the lower back region among women aged 45–54 years. …"
  18. 5058

    Study flow diagram. حسب Maryam Rafiee (10368504)

    منشور في 2025
    "…The highest prevalence of WMSDs (89.5%) was observed in the lower back region among women aged 45–54 years. …"
  19. 5059

    Video 1_Case Report: Allogeneic adipose-derived mesenchymal stem cells for severe feline chronic kidney disease.mp4 حسب Yizhe Song (11859734)

    منشور في 2025
    "…Concurrently, laboratory results revealed a decrease in key renal biomarkers (SCr, BUN, and P) and an amelioration of the non-regenerative anemia. …"
  20. 5060

    Final data used in the study. حسب Maryam Rafiee (10368504)

    منشور في 2025
    "…The highest prevalence of WMSDs (89.5%) was observed in the lower back region among women aged 45–54 years. …"